Pituitary by Hallam, Danial K.
UNIT A5.2Pituitary
Benefiting from superior tissue contrast, multi-planar capability and lack of bone artifact,
MRI readily depicts complex anatomy in and about the pituitary gland. This unit presents
three basic protocols for common indications relating to pathology of the sella and
parasellar region. The protocols differ in emphasis, more than in concept, and share a
basic theme of thin slice high-resolution imaging including the use of gadolinium. With
the possible exception of dynamic imaging, all protocols may be readily performed on
any MR scanner.
BASIC
PROTOCOL 1
MACROADENOMA
Imaging of suspected or known pituitary macroadenoma focuses on evaluation of tumor
extension into adjacent structures, specifically the suprasellar space and cavernous sinus.
Identification of the lesion itself, essentially by definition, is not a taxing problem. The
protocol is quite simple and focuses on demonstrating anatomy in the most useful planes.
The T1-weighted spin echo coronal sequence is the cornerstone of the exam, providing
the majority of useful information.
Table A5.2.1 lists the four sequences which comprise the Basic Protocol. Two optional
sequences are listed. A T2-weighted TSE (turbo spin echo)/FSE (fast spin echo) coronal
sequence is suggested as an option, to provide better characterization of intrasellar
pathology, such as differentiating cyst versus tumor. An optional sixth sequence consisting
of a PD (proton density)/T2-weighted whole brain transverse sequence should be used in
those cases in which sellar pathology is not necessarily the only consideration. Table
A5.2.2 lists the hardware necessary to perform the procedure. Next, stepwise instructions
for performing the protocol are provided. The protocol is not terribly demanding of
scanner hardware and may be performed well on most clinical systems. Basic Protocol 1
generally requires 30 to 45 min to complete.
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Table A5.2.1 Basic Pituitary Protocol: Macroadenoma
Sequence and type of weighting Imaging plane
1. Pilot scan (scout)
2. T1-weighted spin echo Sagittal
3. T1-weighted spin echo Coronal
4. Post-gadolinium T1-weighted spin echo Coronal
Optional sequences
5. T2-weighted TSE/FSE Coronal
6. Dual echo PD/T2-weighted TSE/FSE whole brain Transverse
Table A5.2.2 Equipment Parameters
Coil type Quadrature head coil
Gradient coil strength Whatever the system permits
Cardiac gating No
Peripheral gating For safety only
Respiratory gating No
Respirator If required by patient
Oxygen If required by patient
Motion cushions Useful
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Materials
Normal saline (0.9% NaCl), sterile
Extravascular contrast agent (e.g., Magnevist, Omniscan, or Prohance)
Set up equipment and patient
1. Interview the patient to ensure that he or she has no contraindications such as cardiac
pacemakers or other implants containing ferromagnetic materials. Also be sure to
find out if the patient has any health conditions that may require the presence of
special emergency equipment or special precautions during the scanning procedure.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off mascara or other makeup to avoid local tissue heating and
image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should be instructed not to talk unless absolutely
necessary and to avoid or minimize swallowing and other movements during each
scan—i.e., as long as the banging sounds continue. Between scans, talking and
swallowing are acceptable in most cases, but should be avoided when comparative
positional studies are being performed; the patient will be informed when this is
the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Have the patient mount onto the table. Set up any triggering devices or other
monitoring equipment that is to be used either before or just after the patient lies
down.
7. Center the patient in the head coil. Make sure that the head and neck are constrained
to limit motion, especially if high-resolution scans are to be run.
Generally the patient’s head is fixed so that it is horizontal (not tilted) and the neck and
head lie along the axis of the patient table; other positions may be appropriate depending
on the needs at hand.
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8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Establish an intravenous line from which the contrast agent can be injected, and attach
this line securely to the patient so that movement into or out of the magnet will not
pull at the patient’s arm.
This step may be performed prior to entering the magnet room if necessary to save scanner
time. It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion between the scans run before and after contrast agent injection.
10. Use the centering light to position the patient’s nasion and put him or her into the
center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
11. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: Rapid three-plane positioning pilot
12. To validate the patient’s position, run the system’s pilot (or scout) scan to ensure
correct location of the head in three dimensions, using the imaging sequence given
in Table A5.2.3 or similar parameters.
This sequence usually consists of three orthogonal planes to allow localization. The images
are often also used later to determine where to place the saturation pulses and to set up
total coverage of the volume of interest.
Sequence 2: T1-weighted spin echo sagittal
13. Using images generated in sequence 1, sagittal images are planned to provide thin
slice midline coverage. Set the parameters as indicated in Table A5.2.4.
The scan is best positioned first on the transverse pilot scan. Some angulation may be
needed to provide for true sagittal anatomic imaging. The coverage provided should then
Table A5.2.3 Parameters for Pilot Scan (Scout; Sequence 1)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) 3 planes
Central slice or volume center Run initially at magnet isocenter
Echo time (TE) Minimum
Repeat time (TR) Minimum
Flip angle (FA) 20°
Fields of view (FOVx, FOVy) 300 mm, 300 mm
Resolution (∆x, ∆y) 1.17 mm, 1.56 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 3, one in each of 3 cardinal planes
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Not applicable
Saturation pulses Not applicable
Scan time A few seconds
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be checked on the sagittal scout. A small field of view (FOV) is used to improve in-plane
resolution. In order to avoid aliasing, the (read) oversampling and the no-phase-wrap or
the phase oversampling option should be chosen. Occasionally, large sellar masses may
necessitate increasing the FOV—this should be apparent from the pilot scan. Appropriate
FOV modifications can then be made for all scans focused on the sella. This sequence is
used to accurately position subsequent scans. It provides excellent visualization of midline
structures.
Sequence 3: T1-weighted spin echo coronal
14. Set parameters as indicated in Table A.5.2.5. Using sequence 2, position coronal
images orthogonal to floor of sella or planum sphenoidale.
The center slice should be placed in the middle of the sella. Sequence 3 is the most valuable
sequence of the protocol. It provides excellent visualization of sellar contents and their
Table A5.2.4 Parameters for T1-Weighted Spin Echo Sagittal (Sequence 2)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Midline
Echo time (TE) 14 msec
Repeat time (TR) 500 to 600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (∆x, ∆y) 0.98 mm, 0.86 mm
Number of data points collected (Nx, Ny) 224, 256
Slice thickness (∆z) 3 mm
Number of slices 11
Slice gap (distance factor) 0.5 mm (0.17)
Number of acquisitions (Nacq) 2
Read direction Cranio-caudal
Saturation pulses Inferior may be used
Scan time 4 to 5 min
Table A5.2.5 Parameters for T1-Weighted Spin Echo Coronal (Sequence 3)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Mid-sella
Echo time (TE) 14 msec
Repeat time (TR) 500 to 600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (∆x, ∆y) 0.98 mm, 0.86 mm
Number of data points collected (Nx, Ny) 224, 256
Slice thickness (∆z) 3 mm
Number of slices 11
Slice gap (distance factor) 0.5 mm (0.17)
Number of acquisitions (Nacq) 2
Read direction Cranio-caudal
Saturation pulses Inferior may be used
Scan time 4 to 5 min
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relationship to the cavernous sinus. It also provides visualization of the optic apparatus in
the neighborhood of the pituitary (Figure A5.2.1). Invasion by pituitary adenoma of the
clivus is demonstrated due to the intrinsic contrast afforded by fatty clival marrow (Figure
A5.2.2).
15. Inject the contrast agent, then flush the intravenous line with 10 ml saline. It is
preferable to perform the contrast injection while leaving the patient in the magnet.
A dose of 0.1 mmol/kg is usually given.
Sequence 4: Post-contrast T1-weighted spin echo coronal
16. Repeat sequence 3 with nearly identical parameters and positioning.
Flow compensation is recommended to minimize phase encoding artifact from the cavern-
ous internal carotids. This will increase the TE to ∼17 msec. If a mass is present, this
sequence further characterizes the lesion by demonstrating its enhancement pattern
(Figure A5.2.3).
Figure A5.2.1 Displacement of optic apparatus by su-
prasellar extension of a Rathke’s cleft cyst is demonstrated
on T1-weighted coronal image.
Figure A5.2.2 Invasive pituitary adenoma. Involvement of
clivus and clear invasion of left cavernous sinus demon-
strated by pre-contrast T1-weighted coronal image.
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Sequence 5: T2-weighted TSE/FSE coronal (optional)
17. Set parameters as indicated in Table A5.2.6.
The scan is positioned identically to the T1-weighted coronal studies. This sequence allowsfurther characterization of sellar lesions and is particularly helpful in the setting of
hemorrhage and in differentiating cyst from neoplasm (Figure A5.2.4). Rarely, it will
demonstrate a lesion not otherwise detected. As implemented, the scan will result in some
right-to-left aliasing. This may be solved by employing the no-phase-wrap or the phase-
oversampling option available on many scanners. Such measures will increase the imaging
A B
Figure A5.2.3 (A) The presence of an ademona is suggested by possible mass effect and hypointensity
on non-contrast T1-weighted coronal image. (B) Following contrast, adenoma is clearly demarcated by
decreased enhancement relative to normal pituitary gland.
Table A5.2.6 Parameters for T2-Weighted TSE/FSE Coronal (Sequence 5)
Patient position Supine
Scan type TSE/FSE
Imaging plane (orientation) Coronal
Central slice or volume center Mid-sella
Echo time (TE) 102 msec
Echo train length (ETL; turbo factor) 8 to 11
Repeat time (TR) 3000 msec
Flip angle (FA) 180°a
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.94 mm, 0.70 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 3 mm
Number of slices 11
Slice gap (distance factor) 1 mm (0.33)
Number of acquisitions (Nacq) 3 to 4
Read direction Cranio-caudal
Saturation pulses Inferior may be used
Scan time 3.5 to 5 min
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.
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time of an already lengthy scan. Alternatively, one may simply accept the aliasing artifact
as it does not overlap the sella.
Sequence 6: Dual echo PD/T2-weighted TSE/FSE transverse (optional)
18. The T1-weighted sagittal image (sequence 2) is used to position these transverse
scans.
Set parameters for the PD/T2-weighted dual echo transverse sequence as given in Table
A5.2.7. The scan is positioned graphically to provide whole brain coverage. The slices
Figure A5.2.4 T2-weighted TSE image can be helpful to
better characterize some lesions, as in this case of an arach-
noid cyst.
Table A5.2.7 Parameters for Dual Echo PD/T2-Weighted TSE/FSE Transverse
(Sequences 6 and 18)
Patient position Supine
Scan type TSE/FSE
Imaging plane (orientation) Transverse
Central slice or volume center Position for whole brain coverage
Echo time (TE) 14–17 msec for PD weighted
image and 85–102 msec for
T2-weighted image
Echo train length (ETL) (turbo factor) 5 to 8
Repeat time (TR) 2500–3000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 230 mm
Resolution (∆x, ∆y) 0.94 mm, 0.9 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 5 mm
Number of slices 23
Slice gap (distance factor) 1.5 mm (0.30)
Number of acquisitions (Nacq) 2
Read direction Anterior to posterior
Saturation pulses Inferior may be used
Scan time 2 to 4 min
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should be angled according to an institutional standard for transverse images. The author
recommends using “AC-PC” line as such a standard (see UNIT A5.1). The anterior and
posterior commissures are identified on the T1-weighted sagittal midline image. The slices
of all transverse scans are positioned parallel to a line drawn between the two landmarks.
The sequence provides excellent visualization of the whole brain. It should be used as a
quick whole brain screen when the clinical issue being addressed is not necessarily limited
to the sella.
ALTERNATE
PROTOCOL
STATUS POST TRANSPHENOIDAL SURGERY
This alternate protocol as summarized in Table A5.2.8 should be used in patients who
have undergone transphenoidal surgery for pituitary lesions. The protocol differs from
the Basic Protocol predominantly by the use of fat saturation on post-contrast images.
Also, a second plane post-contrast is helpful in the evaluation of often quite distorted
post-surgical anatomy. This Alternate Protocol should include sequences 1 through 3 as
discussed in Basic Protocol 1. Then perform post-gadolinium imaging in coronal and
sagittal planes with fat saturation. For patient set up and contrast agent injection, see Basic
Protocol 1, steps 1 to 15.
Sequences 7 and 8: Post-contrast T1-weighted spin echo with fat saturation (FS)
1. Set parameters for sequences 7 and 8, as given in Tables A5.2.9 and A5.2.10
respectively.
The sequences are positioned identically to their pre-contrast counterparts. A reduction in
total number of slices (thus TR) may help to limit a somewhat lengthy scan time. Evaluation
of pre-contrast images will determine whether or not this can be done without compromis-
ing the diagnostic utility of the scan.
Table A5.2.8 Alternate Protocol (Status Post Transphenoidal Surgery)
Sequence and type of weighting Imaging plane
7. Post-gadolinium T1-weighted spin echo FS Coronal
8. Post-gadolinium T1-weighted spin echo FS Sagittal
Table A5.2.9 Parameters for FS Post-Contrast T1-Weighted Spin Echo
Coronal (Sequence 7)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Mid-sella
Echo time (TE) 17 msec
Repeat time (TR) 600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (∆x, ∆y) 0.98 mm, 0.86 mm
Number of data points collected (Nx, Ny) 224, 256
Slice thickness (∆z) 3 mm
Number of slices 11
Slice gap (distance factor) 0.5 mm (0.17)
Number of acquisitions (Nacq) 3
Read direction Cranio-caudal
Flow compensation Yes (if available)
Saturation pulses Inferior may be used
Fat suppression Yes
Scan time 5 to 6 min
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BASIC
PROTOCOL 2
MICROADENOMA
In the MR examination for microadenomas, emphasis shifts from evaluation of the extent
of the lesion, primarily to lesion detection. Several approaches exist for meeting this goal.
First, the resolution of the T1 sequences may be increased, with the recognition that the
technique used for macroadenomas already represents a reasonably high-resolution exam.
Further increases in acquisition matrix and decreases in slice thickness come at predict-
able costs both in imaging time and in motion-artifact vulnerability. Second, dynamic
imaging during contrast injection may be applied. In microadenoma detection, dynamic
imaging has received much attention and provides some, albeit limited, increase in
sensitivity (Nagele et al., 1993; Davis et al., 1994; Kucharczyk et al., 1994). Addition of
a T2-weighted sequence usually does not improve sensitivity (Peck et al., 1989; Elster,
1993) and so is not included as part of the standard protocol.
The type of thin-slice, high-resolution exams utilized here push the limits of signal-to-
noise. Some modification of noise-relevant parameters including slice thickness, Nacq, and
acquisition matrix may be needed to yield visually satisfactory images, depending on
individual scanner capabilities. Many centers do not employ high-resolution T1-weighted
sequences as described here. As an alternative approach, the reader may wish to simply
add the dynamic imaging scan to the macroadenoma protocol as their version of a
microadenoma exam (see Background Information, Use of Microadenoma Protocol).
Due to higher Nacq’s utilized on several sequences, as well as setup for the dynamic exam,
total scanning time will be increased 10 to 15 min beyond that required for the macroade-
noma protocol.
Optional sequences for the microadenoma protocol are the same as that for the macroade-
noma protocol and will not be repeated. Table A5.2.11 lists the five sequences that will
be run in Basic Protocol 2.
Table A5.2.10 Parameters for FS Post-Contrast T1-Weighted Spin Echo
Sagittal (Sequence 8)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Midline
Echo time (TE) 17 msec
Repeat time (TR) 500–600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (∆x, ∆y) 0.98 mm, 0.86 mm
Number of data points collected (Nx, Ny) 224, 256
Slice thickness (∆z) 3 mm
Number of slices 11
Slice gap (distance factor) 0.5 mm (0.17)
Number of acquisitions (Nacq) 3
Read direction Cranio-caudal
Flow compensation Yes (if available)
Saturation pulses Inferior may be used
Fat suppression Yes
Scan time 5 to 6 min
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Set up equipment and patient
1. Use the same equipment and perform patient setup as for the previous method (see
Basic Protocol 1).
2. As before (see Basic Protocol 1, step 9), establish an intravenous line.
For the current protocol, the patient will be scanned while contrast is injected. As such, the
i.v. line must be sufficiently long to extend outside the magnet while the patient is being
imaged.
Sequence 9: Pilot scan
3. Run a rapid three-plane positioning pilot scan (see Basic Protocol 1, sequence 1).
Sequence 10: T1-weighted spin echo sagittal
4. Set parameters as indicated in Table A5.2.12.
Using images generated in the pilot scan, sagittal images are planned to provide high-reso-
lution thin slice midline coverage. The scan is best positioned first on the transverse pilot
scan. Some angulation may be needed to provide for true sagittal anatomic imaging. A
small FOV is used to improve in-plane resolution. In order to avoid aliasing, the (read)
oversampling and the no-phase-wrap or the phase oversampling option should be chosen.
Sequence 11: High-resolution T1-weighted spin echo coronal
5. Set parameters as indicated in Table A5.2.13.
Table A5.2.11 Basic Pituitary Microadenoma Protocol
Type of weighting and sequence Imaging plane
9. Pilot scan (scout)
10. T1-weighted spin echo Sagittal
11. T1-weighted spin echo Coronal
12. Dynamic T1-weighted FSE/TSE Coronal
13. Post-gadolinium T1-weighted spin echo Coronal
Table A5.2.12 Parameters for T1-Weighted Spin Echo Sagittal (Sequence 10)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Midline
Echo time (TE) 14 msec
Repeat time (TR) 500-600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mma, 180 mm
Resolution (∆x, ∆y) 0.80 mm, 0.70 mm
Number of data points collected (Nx, Ny) 224, 256
Slice thickness (∆z) 2 to 3 mm
Number of slices 11
Slice gap 0.5 mm
Number of acquisitions (Nacq) 2 to 3
Read direction Cranio-caudal
Saturation pulses Inferior may be used
Scan time 3.5 to 7 min
aNo-phase-wrap or phase-oversampling.
Supplement 3 Current Protocols in Magnetic Resonance Imaging
A5.2.10
Pituitary
The scan is positioned on the T1-weighted sagittal images orthogonal to sellar floor or
planum sphenoidale. This is the most important sequence of a protocol geared towards
detecting subtle lesions within the pituitary (Figure A5.2.5).
Sequence 12: Dynamic T1-weighted TSE/FSE coronal
6. Set parameters as indicated in Table A5.2.14.
Microadenomas usually enhance somewhat later than adjacent normal anterior pituitary
gland. Fast T1-weighted scanning performed during contrast injection may allow detection
of these subtle abnormalities. The scan is run once before, once during and multiple times
after the administration of contrast agent (for 2 to 3 min after injection). Contrast agent
Table A5.2.13 Parameters for High Resolution T1-Weighted Spin Echo
Coronal (Sequences 11 and 13)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Mid-sella
Echo time (TE) 14 msec
Repeat time (TR) 500–600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mma, 180 mm
Resolution (∆x, ∆y) 0.80 mm, 0.70 mm
Number of data points collected (Nx, Ny) 224, 256
Slice thickness (∆z) 2 to 3 mm
Number of slices 11
Slice gap 0.5 mm
Number of acquisitions (Nacq) 2 to 3
Read direction Cranio-caudal
Saturation pulses Inferior may be used
Scan time 3.5 to 7 min
aNo phase-wrap or phase-oversampling.
A B
Figure A5.2.5 (A) Non-contrast T1-weighted coronal image demonstrates a 2.5 mm microadenoma in the
right side of the sella. (B) Following contrast, the lesion is no longer apparent.
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may be administered manually or through the use of an automated injector. Rate of
administration is not critical but should be brisk, with a target of at least 1 ml/sec and
preferably 2 ml/sec.
A rough survey of techniques used by a few different centers for this particular application
disclosed wide variation in parameters. Institutions vary in chosen echo train length (3 to
8), TR (380 msec to 800 msec), number of slices (3 to 7), slice thickness (2 to 3 mm), and
acquisition matrix. The general idea is simply to use a TSE sequence with parameters
providing T1 weighting and run it several times sequentially (Davis et al., 1994). As such,
likely many parameter variations will be acceptable.
Sequence 13: Post-gadolinium T1-weighted spin echo coronal
7. Use parameters as indicated in Table 5.2.13 with identical positioning in sequence
11 and one parameter modification.
Flow compensation option should be used to minimized phase encoding artifact from
cavernous carotids. This option will increase TE to ∼17 msec.
BASIC
PROTOCOL 3
CAVERNOUS SINUS
As with the macroadenoma protocol, evaluation of the cavernous sinus focuses on
T1-weighted imaging in the most useful planes. In this case, transverse imaging is more
helpful than sagittal. Also, T2-weighted imaging is frequently helpful and is included as
part of the standard protocol rather than as an option. Because the anatomy to be evaluated
is part of the skull base, fat suppression is helpful both for T1-weighted post-contrast
imaging and for T2-weighted TSE imaging. Finally, if either a cavernous carotid fistula
or cavernous carotid aneurism is clinically questioned, then 3-D time-of-flight (TOF) MR
angiography is suggested as an option. Table A5.2.15 lists 7 sequences and one optional
sequence for Basic Protocol 3. Basic Protocol 1 generally requires 40 to 60 min to
complete.
Table A5.2.14 Parameters for Dynamic T1-Weighted TSE/FSE Coronal
(Sequence 12)
Patient position Supine
Scan type TSE/FSE
Imaging plane (orientation) Coronal
Central slice or volume center Mid-sella
Echo time (TE) 12 msec
Echo train length (ETL) (turbo factor) 8
Repeat time (TR) 500 msec
Flip angle (FA) 180°a
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.94 mm, 0.70 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 3 mm
Number of slices 7
Slice gap 0 to 0.3 mm
Number of acquisitions (Nacq) 1 to 2
Read direction Cranio-caudal
Saturation pulses Not applicable
Scan time 14 to 28 sec per sequential
acquisition
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.
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Set up equipment and patient
1. Use the same equipment and perform patient setup as for the previous method (see
Basic Protocol 1).
Sequence 14: Pilot scan
2. Run a rapid three-plane positioning pilot scan (see Basic Protocol 1, sequence 1).
Sequence 15: T1-weighted spin echo transverse
3. Set parameters as indicated in Table A5.2.16.
Transverse images are planned off the sagittal pilot scan. The images are positioned
parallel to the planum sphenoidale and should cover from above the sella to the pons.
Sequence 16: T1-weighted spin echo coronal
4. Set parameters as indicated in Table A5.2.17.
Table A5.2.15 Basic Cavernous Sinus Protocol
Sequence and type of weighting Imaging plane
14. Pilot scan (scout)
15. T1-weighted spin echo Transverse
16. T1-weighted spin echo Coronal
17. T2-weighted TSE/FSE FS Coronal
18. Dual echo PD/T2-weighted TSE/FSE whole brain Transverse
19. Post-gadolinium T1-weighted spin echo FS Coronal
20. Post-gadolinium T1-weighted spin echo FS Transverse
Optional sequence
21. 3-D TOF MR angiography (source images)a Transverse
aIf CCF is a specific issue, then 3-D short TR spoiled gradient echo imaging is recommended
(should be performed prior to gadolinium administration).
Table A5.2.16 Parameters for T1-Weighted Spin Echo Transverse (Sequence
15)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Sella
Echo time (TE) 14 msec
Repeat time (TR) 500–600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mma, 180 mm
Resolution (∆x, ∆y) 0.80 mm, 0.70 mm
Number of data points collected (Nx, Ny) 224, 256
Slice thickness (∆z) 3 mm
Number of slices 15
Slice gap (distance factor) 0.5 mm (0.17)
Number of acquisitions (Nacq) 2
Read direction Anterior to posterior
Saturation pulses Inferior
Scan time 4 min
aNo-phase-wrap or phase-oversampling.
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Table A5.2.17 Parameters for T1-Weighted Spin Echo Coronal (Sequence 16)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Mid-sella
Echo time (TE) 14 msec
Repeat time (TR) 500–600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mma, 180 mm
Resolution (∆x, ∆y) 0.80 mm, 0.70 mm
Number of data points collected (Nx, Ny) 224, 256
Slice thickness (∆z) 4 mm
Number of slices 15
Slice gap (distance factor) 1 mm (0.25)
Number of acquisitions (Nacq) 2
Read direction Cranio-caudal
Saturation pulses Inferior
Scan time 4 min
aNo-phase-wrap or phase-oversampling may be used.
Table A5.2.18 Parameters for T2-Weighted TSE/FSE Coronal (Sequence 17)
Patient position Supine
Scan type TSE/FSE
Imaging plane (orientation) Coronal
Central slice or volume center Mid-sella
Echo time (TE) 102 msec
Echo train length (ETL) (turbo factor) 8 to 11
Repeat time (TR) 3000 msec
Flip angle (FA) 180°a
Fields of view (FOVx, FOVy) 180 mmb, 180 mm
Resolution (∆x, ∆y) 0.94 mm, 0.70 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 4 mm
Number of slices 15
Slice gap (distance factor) 1 mm (0.25)
Number of acquisitions (Nacq) 3 to 4
Read direction Cranio-caudal
Saturation pulses Inferior
Fat suppression Yes
Scan time 4 min
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.
bNo-phase-wrap or phase-oversampling may be used.
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The scan is positioned on the pilot sagittal with images orthogonal to sellar floor or planum
sphenoidale. The scan should cover from mid-pons to mid-orbit.
Sequence 17: T2-weighted TSE/FSE coronal
5. Set parameters as indicated in Table A5.2.18.
The scan is positioned identically to the T1-weighted coronal study. This scan provides
T2-weighted information about the contents of the cavernous sinus. Fat saturation allowsfor evaluation of pathology in or adjacent to the skull base.
Sequence 18: Dual echo PD/T2-weighted TSE/FSE whole brain transverse
6. The scan is identical to that of Sequence 6 of the Basic Protocol 1. Set parameters as
indicated in Table A5.2.7.
A quick whole brain screening sequence is often helpful in patients with symptoms related
to cavernous sinus pathology.
Sequence 19: FS post-contrast T1-weighted spin echo coronal
7. Set parameters as indicated in Table A5.2.19 and run with identical positioning to the
pre-contrast T1-weighted coronal sequence. Repeat step 15 in Basic Protocol 1.
The time required for the FS pulse will increase TE and likely require some increase in TR
to provide adequate coverage. The TR should be kept below ∼700 msec to maintain proper
T1 weighting. A decrease in total number of slices is often required and usually acceptable
depending upon the anatomy of the patient and any pathology demonstrated on the
pre-contrast scan. In exceptional circumstances, it may be necessary to run two separate
measurements to provide adequate coverage. An increase in Nacq is often needed to
maintain high image quality.
Sequence 20: FS post-contrast T1-weighted transverse
8. Set parameters as indicated in Table A5.2.20 and run with identical positioning to the
pre-contrast T1-weighted transverse sequence.
Table A5.2.19 Parameters for FS Post-Contrast T1-Weighted Spin Echo
Coronal (Sequence 19)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Mid-sella
Echo time (TE) 17 msec
Repeat time (TR) 650 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mma, 180 mm
Resolution (∆x, ∆y) 0.94 mm, 0.70 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 4 mm
Number of slices 15 or as allowed
Slice gap (distance factor) 1 mm (0.25)
Number of acquisitions (Nacq) 3
Read direction Cranio-caudal
Flow compensation Yes (if available)
Saturation pulses Inferior may be used
Fat suppression Yes
Scan time 6 min
aNo-phase-wrap or phase-oversampling may be used.
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Table A5.2.20 Parameters for FS Post-Contrast T1-Weighted Spin Echo
Transverse (Sequence 20)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Sella
Echo time (TE) 17 msec
Repeat time (TR) 650 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mma, 180 mm
Resolution (∆x, ∆y) 0.94 mm, 0.70 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 3 mm
Number of slices 15 or as allowed
Slice gap (distance factor) 0.5 mm (0.17)
Number of acquisitions (Nacq) 3
Read direction Anterior to posterior
Flow compensation Yes (if available)
Saturation pulses Inferior may be used
Fat suppression Yes
Scan time 6 min
aNo-phase-wrap or phase-oversampling may be used.
Table A5.2.21 Parameters for 3-D Time-of-Flight MR Angiogram (Sequence 21)
Patient position Supine
Scan type 3-D short TR spoiled gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Sella
Echo time (TE) Minimum (or 6.9 msec)
Repeat time (TR) Minimum (or 36 msec)
Flip angle (FA) 25°
Fields of view (FOVx, FOVy) 160 mm, 220 mm
Resolution (∆x, ∆y) 0.83 mm, 0.86 mm
Number of data points collected (Nx, Ny) 192, 256
Slice thickness (∆z) 1 mm
Number of slices 50–64
Slice gap 0
Number of acquisitions (Nacq) 1
Read direction Anterior to posterior
Flow compensationa Yes
Saturation pulses None
Scan time ∼6 to 7 min
aVelocity (flow) compensation in read and slice-select directions.
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Sequence 21: 3-D TOF MR angiogram (optional)
9. Set parameters as indicated in Table A5.2.21.
The scan is positioned just as prior transverse acquisitions. If this option is chosen, it must
be run prior to gadolinium enhancement (before sequence 19). When the presence of a
cavernous-carotid fistula (CCF) is questioned, a 3-D TOF angiogram is a helpful step. The
exam is interpreted directly from source images where the observation of flow-related
enhancement in the cavernous sinus indicates the presence of a CCF. Processing the image
data to obtain maximum intensity projections can of course be used to aid evaluation of
arterial anatomy in the usual fashion (see Chapter A1).
COMMENTARY
Background Information
Within the modest limits of the sella turcica
and environs, an impressive array of anatomy
merges, reflecting elements of neural, endo-
crine, vascular, meningeal and bony tissues.
The multi-planar capability and tissue contrast
afforded by MRI provides detailed information
about the pathology and anatomy of this region.
With tumors of the anterior pituitary compris-
ing 10% to 15% of all intracranial neoplasms,
careful attention to the MRI evaluation of the
sella is paramount (Kovacs and Horvath, 1986).
As a testimony to the tremendous intrinsic
soft tissue contrast demonstrated by MRI, the
simplest of sequences—a T1-weighted spin
echo sequence performed in the coronal
plane—provides much of the desired informa-
tion. The T1-weighted coronal sequence iden-
tifies most, but not all, microadenomas. The
sequence also evaluates suprasellar extension
of sellar lesions and the presence of optic ap-
paratus compression. Despite the use of T2
weighting and various contrast enhancement
techniques, the two limitations of this se-
quence, incomplete sensitivity to microade-
nomas and evaluation of cavernous sinus inva-
sion, remain problematic.
T1-weighted non-contrast imaging detects
most microadenomas, with the actual sensitiv-
ity varying in different series between 60% and
80% (Kucharczyk et al., 1986; Nichols et al.,
1988; Lundin et al., 1991; Elster, 1993). Post-
gadolinium imaging improves sensitivity
mildly, detecting ∼5% to 10% more lesions
(Macpherson et al., 1989; Newton et al., 1989;
Steiner et al., 1989; Stadnik et al., 1990). Fi-
nally, use of dynamic enhanced techniques pro-
vides visualization of 5% to 20% more lesions,
increasing the overall sensitivity of the com-
plete MR exam to 80% to 90%. The improve-
ment in sensitivity provides the motivation for
the dedicated microadenoma protocol. How-
ever, with each additional step, the MRI be-
comes lengthier, more expensive, and, in the
case of the dynamic study, logistically more
complex. Hence, some consideration should be
given to the need for such an exhaustive search.
Use of microadenoma protocol
Not all microadenomas must be detected.
The need for definitive microadenoma detec-
tion is determined by many factors relating to
results of endocrine tests, patient factors, and
institutional habits. For a recent review of the
issue, the reader is referred to Elster (1994). In
many cases, reliable diagnosis of microade-
noma can be made by clinical history and re-
sults of serum hormone assays. If an institution
treats all such neoplasms medically, then detec-
tion of the lesion by imaging is not necessary
and the MRI is used only to exclude other
pathology and perhaps as a baseline. In this
event, an all-out MR search for the lesion is
unnecessary. However, in some institutions,
surgery is applied as a front-line therapy. Also,
medical therapy may be ineffective or not tol-
erated by the patient. In such situations, detec-
tion of the lesion preoperatively becomes im-
portant.
As a first step in increasing sensitivity to
microadenoma detection, the resolution of the
T1-weighted coronal sequence may be further
increased. To the author’s knowledge, the util-
ity of this rather straightforward move has not
been subjected to a careful, controlled prospec-
tive study. However, given the small size of
lesions to be detected and the proven value of
a T1-weighted coronal sequence, it makes in-
herent sense. Of course, several problems may
arise. First, the quality of implementation on
individual scanners will vary. The sequence
pushes the limits of image signal-to-noise and
some experimentation with acquisition matrix
(number of data points collected), slice thick-
ness, and number of acquisitions will likely be
necessary to achieve a visually pleasing and
hence useful exam. Second, higher resolution
will doubtless uncover an increasing number of
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the so-called pituitary incidentalomas (Chong
et al., 1994; Teramoto et al., 1994). The exist-
ence of fairly frequent incidental abnormalities
should be kept in mind in proper interpretation
of high-resolution pituitary exams.
Differential temporal enhancement of pitui-
tary neoplasms provides another dimension
along which they may be separated from the
normally enhancing gland. The general ap-
proach is to perform some form of fast T1-
weighted imaging in the coronal plane using
just a few slices located in the mid-sella. The
sequence is repeated serially just before, at the
beginning of, and several times after a bolus
injection of contrast agent, up to ∼2 min. In this
way, microadenomas, which usually enhance
in delayed fashion compared to the normal
adenohypophysis, may be identified. Fast T1-
weighted imaging may be achieved in a number
of ways, and several different approaches have
been applied successfully, including FSE/TSE
sequences, gradient-recalled sequences, and
keyhole imaging (Nagele et al., 1993; Davis et
al., 1994; Kucharczyk et al., 1994). In the
author’s experience, the application of a T1-
weighted TSE/FSE sequence, as indicated in
Basic Protocol 2, provides reliable and useful
information, and is available on many current
scanners. In the past, approaches employing
gradient-recalled sequences with fairly long
TE’s suffered from skull base and sphenoid
sinus related susceptibility artifacts. With
shorter TE’s (down to 2 msec) afforded by newer
scanners, such artifacts are minimized and gra-
dient-echo sequences in this application now
represent a viable option. Keyhole dynamic
imaging likely has advantages, but is not com-
monly available.
Cavernous sinus invasion by pituitary
adenoma
Identification of cavernous sinus invasion
by pituitary adenomas carries important clini-
cal implications. For the neurosurgeon, an ade-
noma invading the cavernous sinus cannot usu-
ally be successfully removed, so once invasion
is diagnosed, the goal of transphenoidal surgery
shifts from tumor removal to tumor debulking.
MRI does not often allow for definitive evalu-
ation of invasion as the medial wall of the
cavernous sinus is generally not visualized even
with high-resolution imaging. As with most
pituitary pathology, the T1-weighted spin echo
coronal sequence provides the most useful in-
formation. Clear signs of invasion include en-
casement of the intracavernous carotid artery
by tumor, cavernous sinus expansion, and inva-
sion beyond the lateral wall of the cavernous
sinus. For less obvious cases, several classifi-
cation schemes have been devised for predict-
ing the likelihood of invasion, generally using
the intracavernous carotid artery as a landmark
(Scotti et al., 1988; Knosp et al., 1993).
Pathology primary to the cavernous sinus
The cavernous sinus protocol, Basic Proto-
col 3, focuses on pathology primary to the
cavernous sinus. Reflecting the wide variety of
potential pathology, the protocol is somewhat
longer and uses several types of scan weighting
along with enhancement. The protocol may not
be ideal for each patient and appropriate modi-
fications will be necessary from time to time.
Symptoms related to the cavernous sinus derive
from dysfunction of its cranial nerve and ve-
nous contents. If the symptomatology is limited
to just one or a few of the cranial nerves present,
then one of several other similar protocols may
be more appropriate. Symptoms related to cra-
nial nerves III, IV and VI may be better evalu-
ated by an orbit protocol (see UNIT A7.5). If only
cranial nerve V symptoms are present, then a
dedicated protocol for imaging the full extent
of this important nerve is likely more suitable
(see UNIT A7.2).
Symptoms and signs of a cavernous-carotid
fistula are often dramatic and the diagnosis
clinically apparent. If MRI evaluation of the
condition is desired, then 3-D TOF MRA
should be used (sequence 21 of Basic Protocol
3). Inspection of source images for flow related
enhancement in the cavernous sinus has been
shown to be more sensitive to the presence of
a CCF (Hirai et al., 1998). It should be noted
that not all CCFs will be positive on an MRA
and catheter angiography may be necessary. In
this fairly specific clinical context, not all of the
sequences in Basic Protocol 3 will be necessary.
Critical Parameters and
Troubleshooting
Fat saturation techniques will exaggerate
susceptibility artifacts related to dental hard-
ware. Such artifacts are not as common in the
sella as in the orbits and paranasal sinuses but
nonetheless can occasionally be problematic.
As a first step to deal with such a problem,
simply repeat the sequence without the fat satu-
ration pulse. In the case of post-contrast imag-
ing, if a pre-contrast scan in the same plane
exists, then interpretation is still certainly pos-
sible, albeit perhaps a bit more demanding. If
T2-weighted FS imaging is desired, as in the
cavernous sinus protocol, then a T2-weighted
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STIR (short tau inversion recovery) scan pro-
vides a comparable substitute.
Anticipated Results
The pituitary protocols will provide excel-
lent visualization of the sella and its key neigh-
boring relationships. The pituitary gland, in-
fundibulum, and sella itself will be demon-
strated. Pathology in the adjacent sphenoid
sinus and clivus will be apparent. The optic
chiasm, as well as adjacent optic nerves and
tracts, will be well identified and their displace-
ment by pituitary pathology characterized. All
macroadenomas will be detected along with
most microadenomas. Some information re-
garding the possibility of cavernous sinus inva-
sion will be present.
The cavernous sinus protocol will identify
and characterize contents of the cavernous si-
nus. Multiple sequences are employed in two
advantageous planes in an effort to detail the
intricate anatomy of this region. Reflecting the
variety of pathology which may be present, T1
weighting, T2 weighting, and contrast agent
enhancement sequences are all utilized. Using
this approach, small tumors and inflammatory
processes of the nerves of the sinus will be
demonstrated. The morphology of the cavern-
ous carotids will be demonstrated, although not
quite as well as by catheter angiography. The
presence of abnormalities of cavernous sinus
venous flow will be visualized.
Literature Cited
Chong, B.W., Kucharczyk, W., Singer, W., and
George, S. 1994. Pituitary gland MR: a compara-
tive study of healthy volunteers and patients with
microadenomas. Am. J. Neuroradiol. 15:675-
679.
Davis, W.L., Lee, J.N., King, B.D., and Harnsberger,
H.R. 1994. Dynamic contrast-enhanced MR im-
aging of the pituitary gland with fast spin-echo
technique. J. Magn. Reson. Imaging 4:509-511.
Elster, A.D. 1993. Modern imaging of the pituitary.
Radiology 187:1-14.
Elster, A.D. 1994. High-resolution, dynamic pitui-
tary MR imaging: Standard of care or academic
pastime? [comment]. Am. J. Roentgenol.
163:680-682.
Hirai, T., Korogi, Y., Hamatake, S., Ikushima, I.,
Sugahara, T., Sigematsu, Y., Higashida, Y., and
Takahashi, M. 1998. Three-dimensional FISP
imaging in the evaluation of carotid cavernous
fistula: comparison with contrast-enhanced CT
and spin-echo MR. Am. J. Neuroradiol. 19:253-
259.
Knosp, E., Steiner, E., Kitz, K., and Matula, C. 1993.
Pituitary adenomas with invasion of the cavern-
ous sinus space: A magnetic resonance imaging
classification compared with surgical findings
[see comments]. Neurosurgery 33:610-617; dis-
cussion 617-618.
Kovacs, K., and Horvath, E. 1986. Tumors of the
Pituitary Gland. Armed Forces Institute of Pa-
thology, Washington, D.C.
Kucharczyk, W., Davis, D.O., Kelly, W.M., Sze, G.,
Norman, D., and Newton, T.H. 1986. Pituitary
adenomas: high-resolution MR imaging at 1.5 T.
Radiology 161:761-765.
Kucharczyk, W., Bishop, J.E., Plewes, D.B., Keller,
M.A., and George, S. 1994. Detection of pitui-
tary microadenomas: comparison of dynamic
keyhole fast spin-echo, unenhanced, and con-
ventional contrast-enhanced MR imaging [see
comments]. Am. J. Roentgenol. 163:671-679.
Lundin, P., Bergstrom, K., Thuomas, K.A., Lund-
berg, P.O., and Muhr, C. 1991. Comparison of
MR imaging and CT in pituitary macroade-
nomas. Acta Radiol. 32:189-196.
Macpherson, P., Hadley, D.M., Teasdale, E., and
Teasdale, G. 1989. Pituitary microadenomas.
Does Gadolinium enhance their demonstration?
Neuroradiology 31:293-298.
Nagele, T., Petersen, D., Klose, U., Grodd, W.,
Opitz, H., Gut, E., Martos, J., and Voigt, K. 1993.
Dynamic contrast enhancement of intracranial
tumors with snapshot-FLASH MR imaging. Am.
J. Neuroradiol. 14:89-98.
Newton, D.R., Dillon, W.P., Norman, D., Newton,
T.H., and Wilson, C.B. 1989. Gd-DTPA-en-
hanced MR imaging of pituitary adenomas. Am.
J. Neuroradiol. 10:949-954.
Nichols, D.A., Laws, E.R., Jr., Houser, O.W., and
Abboud, C.F. 1988. Comparison of magnetic
resonance imaging and computed tomography in
the preoperative evaluation of pituitary ade-
nomas. Neurosurgery 22:380-385.
Peck, W.W., Dillon, W.P., Norman, D., Newton,
T.H., and Wilson, C.B. 1989. High-resolution
MR imaging of pituitary microadenomas at 1.5
T: experience with Cushing disease. Am. J.
Roentgenol. 152:145-151.
Scotti, G., Yu, C.Y., Dillon, W.P., Norman, D.,
Colombo, N., Newton, T.H., De Groot, J., and
Wilson, C.B. 1988. MR imaging of cavernous
sinus involvement by pituitary adenomas. Am. J.
Roentgenol. 151:799-806.
Shellock, F.G. 1996. Pocket Guide to MR Proce-
dures and Metallic Objects. Lippincott-Raven,
Philadelphia.
Stadnik, T., Stevenaert, A., Beckers, A., Luypaert,
R., Buisseret, T., and Osteaux, M. 1990. Pituitary
microadenomas: Diagnosis with two-and three-
dimensional MR imaging at 1.5 T before and
after injection of gadolinium. Radiology
176:419-428.
Steiner, E., Imhof, H., and Knosp, E. 1989. Gd-
DTPA enhanced high resolution MR imaging of
pituitary adenomas. Radiographics 9:587-598.
Current Protocols in Magnetic Resonance Imaging Supplement 3
A5.2.19
Miscellaneous
Brain Pathology
Teramoto, A., Hirakawa, K., Sanno, N., and Osa-
mura, Y. 1994. Incidental pituitary lesions in
1,000 unselected autopsy specimens. Radiology
193:161-164.
Key References
Shellock, 1996. See above.
Covers a number of important patient management
issues related to MR imaging, including recom-
mended safety procedures, a list of metallic implants
that have been tested for MR compatibility, and a
list of other sources on MR safety.
Contributed by Danial K. Hallam
University of Washington
Seattle, Washington
Supplement 3 Current Protocols in Magnetic Resonance Imaging
A5.2.20
Pituitary
